Home > Boards > US OTC > Homeland Security > Sniffex Inc. (SNFX)

re CEXI... I strongly urge you to learn

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Doubloon Member Profile
Followed By 374
Posts 16,992
Boards Moderated 0
Alias Born 09/10/00
160x600 placeholder
Doubloon   Tuesday, 08/30/05 03:26:11 PM
Re: dubyah post# 14
Post # of 40 
re CEXI... I strongly urge you to learn how to do your research

>loss since inception $14,552,534

>going concern...CDEX shareholders will experience significant dilution if we issue additional equity to fund operations or acquire businesses or technologies.

If working capital or future acquisitions are financed through the issuance of equity securities, CDEX shareholders will experience significant dilution. In addition, securities issued in connection with future financing activities or potential acquisitions may have rights and preferences senior to the rights and preferences of the currently outstanding CDEX shares of common stock. The conversion of future debt obligations into equity securities could also have a dilutive effect on our shareholders. Regardless of whether our cash assets prove to be inadequate to meet our operational needs, we may elect to compensate providers of services by issuing stock in lieu of cash.

> recent SB-2 filing for 2,377,656 shares

>basically a research company no product
CDEX Inc. specializes in the development of marketable products from innovative technologies. Our primary research efforts are currently directed toward identification and validation of substances in environments that are difficult to monitor. Within this focus, CDEX’s efforts are centered in chemical detection through the use of excitation energy sources for substance identification, e.g., x-rays and ultra-violet light.

There is no substitute for conducting your own research
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences